We are live on ! Find out more
ZVSAW

ZyVersa Therapeutics, Inc. Warrants
ZVSAW

Delisted

ZVSAW was delisted on the 20th of December, 2022.

Back to rankings

1 hedge funds and large institutions have $105 invested in ZyVersa Therapeutics, Inc. Warrants in 2023 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $105 → $105 ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ZVSAW Hedge Fund Activity: Q3 2023 in Review

1 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in ZyVersa Therapeutics, Inc. Warrants (ZVSAW) for Q3 2023, worth a combined $105 — unchanged from a quarter earlier.

Fund positioning in ZVSAW was balanced in Q3 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held ZyVersa Therapeutics, Inc. Warrants (ZVSAW) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $105 of ZyVersa Therapeutics, Inc. Warrants stock for Q3 2023, unchanged quarter-over-quarter.
  • 0 funds opened new ZyVersa Therapeutics, Inc. Warrants positions in Q3 2023 and 0 closed out.

Based on aggregated 13F filings for Q3 2023.